Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News ObsEva SA (EM) OBSEF

Healthcare Biotechnology
ObsEva SA, a biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health. It develops Nolasiban, an oral oxytocin receptor agonist for improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.

Current News (EXPM:OBSEF)

ObsEva Announces Delisting from SIX Swiss Exchange and Exemption from Certain Obligations Associated with the Maintenance of Listin

GlobeNewswire April 3, 2024

ObsEva Announces Update on Board of Directors

GlobeNewswire March 19, 2024

ObsEva Announces Wind-Down of Operations and Notifies SIX that it Will Lack the Resources to Establish Audited IFRS Financial Statements for 2023

GlobeNewswire February 28, 2024

Geneva Court Grants Temporary Moratorium to ObsEva

GlobeNewswire January 31, 2024

ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals

GlobeNewswire November 30, 2023

Organon Returns Ebopiprant to XOMA

GlobeNewswire October 27, 2023

ObsEva Files half Year 2023 Financial Statements

GlobeNewswire September 27, 2023

ObsEva Recovers Full Worldwide Rights on Nolasiban

GlobeNewswire July 13, 2023

Annual General Meeting 2023

GlobeNewswire June 8, 2023
View More News ››

Opinion & Analysis (EXPM:OBSEF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:OBSEF)

What's behind the insider purchase of 4M shares?

Friday's volume was insaaaaaane. Perhaps there's something spectacular in tomorrow's earnings. 
Buzzworth - March 5, 2023

still holding this stock

starting to pick up in price,so glta shareholders.
coolfooldumbguy - December 31, 2019

added more of this one

to my position,so glta.
coolfooldumbguy - December 19, 2019

it's a buy today for me

started a position in this stock,it was oversold,so glta.
coolfooldumbguy - December 10, 2019
View more Bullboard ››

AE Fuels Corporation

AE Fuels Corporation

AE Fuels Corporation (TSXV: AEF) is a battery materials company focused on the extraction and purification of minerals ...
View More »

Podcasts